LUNGSEARCH: Lung Cancer Screening, Early Detection, Biomarkers and New Therapeutic Targets
SEARCH
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (74)
2024
-
Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins
Microchemical Journal, Vol. 199
-
Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience
Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15
-
Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP
Archivos de Bronconeumologia
-
Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience
Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100
-
Sleep apnoea increases biomarkers of immune evasion, lymphangiogenesis and tumour cell aggressiveness in high-risk patients and those with established lung cancer
ERJ Open Research, Vol. 10, Núm. 1
-
The tip of the iceberg: a plethora of lung nodules in the general population
The European respiratory journal
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422
2023
-
IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer
Journal of Thoracic Oncology, Vol. 18, Núm. 5, pp. 564-575
-
Important steps towards a big change for lung health: a joint approach by the European Respiratory Society, the European Society of Radiology and their partners to facilitate implementation of the European Union’s new recommendations on lung cancer screening
ERJ Open Research
-
Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients
Journal of Translational Medicine, Vol. 21, Núm. 1
-
Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease
International Journal of Molecular Sciences, Vol. 24, Núm. 18
-
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer
EMBO Reports, Vol. 24, Núm. 8
-
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine, Vol. 15, Núm. 1
-
Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent
Journal of Proteome Research, Vol. 22, Núm. 11, pp. 3499-3507
2022
-
Deep learning-based lesion subtyping and prediction of clinical outcomes in COVID-19 pneumonia using chest CT
Scientific Reports, Vol. 12, Núm. 1
-
Emphysema: the risk of cancer and the impact on cancer care
ERS Monograph, Vol. 2022, Núm. 98, pp. 105-117
-
The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors
Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 838-851
2021
-
Bringing onco‐innovation to Europe’s healthcare systems: The potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine
Cancers, Vol. 13, Núm. 3, pp. 1-12
-
COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort
Respiratory research, Vol. 22, Núm. 1, pp. 36
-
Molecular biomarkers in early stage lung cancer
Translational Lung Cancer Research, Vol. 10, Núm. 2, pp. 1165-1185